Un « preprint » nous annonce enfin une bonne nouvelle à propos d’un vaccin.
Pourvu que ça se confirme, apparemment le Pfizer Biontech réduirait aussi la charge virale.
« Beyond their substantial protection of individual vaccinees, it is hoped that the COVID-19 vaccines would reduce viral load in breakthrough infections thereby further suppress onward transmission. Here, analyzing positive SARS-CoV-2 test results following inoculation with the BNT162b2 mRNA vaccine, we find that the viral load is reduced 4-fold for infections occurring 12-28 days after the first dose of vaccine. These reduced viral loads hint to lower infectiousness, further contributing to vaccine impact on virus spread. »